News
GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...
GSK will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs. The British pharma giant said Wednesday that it will pay the ...
In recent years, the U.K.-listed pharma giant has called increasingly on U.S. law firms for its transactional work.
4h
Capital Market on MSNStock Alert: Tata Motors, GlaxoSmithKline Pharma, Honeywell Automation, Bharti AirtelEicher Motors, Aditya Birla Real Estate, ADF Foods, Agi Greenpac, Ajmera Realty & Infra India, Akzo Nobel India, Apar ...
6h
TipRanks on MSNGSK Advances Share Buyback Program with Recent AcquisitionGlaxoSmithKline (GSK) has announced the repurchase of 783,700 of its ordinary shares as part of its ongoing buyback program, executed through Citigroup Global Markets Limited. This transaction is part ...
UnitedHealth Group announced that CEO Andrew Witty is stepping down due to personal reasons, and the company is forced to ...
Explore more
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...
UnitedHealth CEO Andrew Witty is stepping down for personal reasons and the nation’s largest health insurer suspended its ...
The head of UnitedHealth Group is stepping down, ending a rocky four years marked by rising medical costs, a major ...
GlaxoSmithKline Pharmaceuticals share price today: Shares of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit an all-time high of ₹3,147.45, surging 10 per cent on the BSE in Thursday’s intra-day ...
The initiative funds vaccine purchases from drug manufacturers including Merck and GlaxoSmithKline at a discount, while state health departments implement the program and enroll medical providers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results